Prostate Cancer - Results from #26440

Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml - Abstract January 23, 2012

Optimising repeat prostate biopsy decisions and procedures - Abstract January 23, 2012

Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series - Abstract January 23, 2012

Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer - Abstract January 23, 2012

Obstructive uropathy from locally advanced and metastatic prostate cancer: An old problem with new therapies - Abstract January 23, 2012

Environment as a potential key determinant of the continued increase of prostate cancer incidence in martinique - Abstract January 23, 2012

Controversy over treatment options in clinical T3 prostate cancer - Abstract January 23, 2012

Prostatectomy-pros and cons on open surgery/laparoscopic surgery/robot-assisted surgery - Abstract January 23, 2012

Castration-resistant prostate cancer: Where are we going? - Abstract January 23, 2012

A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer - Abstract January 23, 2012

Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml - Abstract January 23, 2012

NutriTRAILomics in prostate cancer: Time to have two strings to one's bow - Abstract January 23, 2012

Comparative analysis of three risk assessment tools in Australian patients with prostate cancer - Abstract January 20, 2012

Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer - Abstract January 20, 2012

MR imaging of treated prostate cancer - Abstract January 20, 2012

Milk intake in early life and risk of advanced prostate cancer - Abstract January 20, 2012

Pros and cons of active surveillance for low-risk prostate cancer - Abstract January 20, 2012

Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer - Abstract January 20, 2012

Relation between prostate gland volume and some histological markers of malignancy - Abstract January 20, 2012

Integrating multiparametric prostate MRI into clinical practice - Abstract January 20, 2012

Page 1323 of 1436